Silo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD

Silo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD

Summary

Federal initiatives focused on PTSD and related conditions appears to validate need for new and novel approaches to mental health treatment

Description

Federal initiatives focused on PTSD and related conditions appears to validate need for new and novel approaches to mental health treatment

Original reporting

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Open original source

Related coverage